tokens: OAP confers to Oct-2 responsivity to both TPA/Ca2+ and RA , since specific mutations of the AP-1/OAP-binding site significantly reduce the transactivation by Oct-2 in response to TPA and Ca2+ and abolish the inhibition by RA .